Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC
Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, from left, David Ricks, chief executive officer of Eli Lilly & Co., and Martin Makary, commissioner of the Food and Drug Administration (FDA), in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM
- Product Code
- ILEA004880140
- Registered date
- 2025/11/06 00:00:00
- Credit
- Abaca Press / Kyodo News Images
- Media source
- Pool/ABACA
- Media size
- 4000 × 2667 pixel
- Resolution
- 72 dpi
- Deployment size
- 4.60(MB)*
- Special instruction
*File size when opened in Photoshop, etc.
